Finn Patrick John
Transaction: 07/23/2026
SELL
Change
-2,238
Price
$93.89
Filing
07/27/2026
Type
SELL
Twist Bioscience Corporation
TWST • Medical - Diagnostics & Research
$124.72
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$7.78B
Growth
55.2%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 23.1%Manageable debt level · 0.29Healthy liquidity · 3.64Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$124.72
Change0.00%
Shares Out62.40M
Market Cap$7.78B
Enterprise Value$7.71B
52W Range23.30 - 106.58
Beta2.16
P/E-56.93
P/S18.02
P/B17.46
P/FCF-83.58
EV/Sales17.85
Price$124.72
Change0.00%
Shares Out62.40M
Market Cap$7.78B
Enterprise Value$7.71B
52W Range23.30 - 106.58
Beta2.16
P/E-56.93
P/S18.02
P/B17.46
P/FCF-83.58
EV/Sales17.85
EV/EBITDA-63.78
EV/FCF-82.79
Earnings Yield-1.76%
FCF Yield-1.20%
Dividend Yield0.00%
Gross Margin50.72%
Oper. Margin-36.18%
Profit Margin-20.63%
Debt/Eq0.29
Current Ratio3.64
Quick Ratio3.33
Revenue 5Y55.16%
Target$104.67
Target Upside-16.08%
Target Median$107.00
Target Range89.00 - 120.00
Volume1.24M
Avg Volume1.73M
EPS Surprise-0.13
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Positive revenue growth · 23.1%Manageable debt level · 0.29Healthy liquidity · 3.64Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
86/100
Bullish
Bullish
11
Hold
2
Bearish
1
Price Target
2026-08-05
Low
$85.00
Mean
$101.33
Median
$102.00
High
$120.00
Insider Transactions
Recent executive and insider activity
Laponis Adam
Transaction: 07/09/2026
SELL
Change
-2,399
Price
$94.33
Filing
07/13/2026
Type
SELL
Leproust Emily M.
Transaction: 06/25/2026
SELL
Change
-18,880
Price
$95.00
Filing
06/26/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Finn Patrick John | SELL | -2,238 | $93.89 | 07/23/2026 | 07/27/2026 |
| Laponis Adam | SELL | -2,399 | $94.33 | 07/09/2026 | 07/13/2026 |
| Leproust Emily M. | SELL | -18,880 | $95.00 | 06/25/2026 | 06/26/2026 |
| Cho Dennis | SELL | -14,205 | $89.75 | 06/24/2026 | 06/26/2026 |
| Leproust Emily M. | SELL | -1,688 | $87.32 | 06/22/2026 | 06/24/2026 |
| Cho Dennis | SELL | -346 | $87.32 | 06/22/2026 | 06/24/2026 |
| Green Paula | SELL | -291 | $87.32 | 06/22/2026 | 06/24/2026 |
| Green Paula | SELL | -26,137 | $23.33 | 06/15/2026 | 06/17/2026 |
| Green Paula | SELL | -2,028 | $82.17 | 06/15/2026 | 06/17/2026 |
| WERNER ROBERT F. | SELL | -500 | Not reported | 06/08/2026 | 06/10/2026 |
| Leproust Emily M. | SELL | -2,265 | $69.84 | 06/08/2026 | 06/10/2026 |
| Green Paula | SELL | -884 | $69.84 | 06/08/2026 | 06/10/2026 |
| Cho Dennis | SELL | -402 | $69.84 | 06/08/2026 | 06/10/2026 |
| Laponis Adam | SELL | -4,000 | $70.00 | 05/29/2026 | 06/02/2026 |
| Cho Dennis | SELL | -14,205 | $69.75 | 05/29/2026 | 06/02/2026 |
| Starovasnik Melissa A. | SELL | -2,500 | $68.00 | 05/28/2026 | 06/01/2026 |
| Leproust Emily M. | SELL | -16,470 | $8.82 | 05/28/2026 | 06/01/2026 |
| Leproust Emily M. | SELL | -6,465 | $68.61 | 05/28/2026 | 06/01/2026 |
| Leproust Emily M. | BUY | +25,017 | $8.82 | 05/27/2026 | 05/28/2026 |
| Leproust Emily M. | SELL | -1,265 | $66.28 | 05/27/2026 | 05/28/2026 |